Table 4.
BPND
| HC | SCZ | |||||
|---|---|---|---|---|---|---|
| Baseline | Post-Amph | ΔBPND | Baseline | Post-Amph | ΔBPND | |
| DLPFC | 1.8 ± 0.5 | 1.6 ± 0.4 | −7.5 ± 11.4% | 1.8 ± 0.7 | 1.8 ± 0.6 | 1.8 ± 11.1% |
| OFC | 1.8 ± 0.5 | 1.7 ± 0.4 | −5.5 ± 13.9% | 1.9 ± 0.7 | 1.9 ± 0.6 | 2.6 ± 11.3% |
| MFC | 1.9 ± 0.5 | 1.8 ± 0.4 | −4.7 ± 13.2% | 2.0 ± 0.8 | 2.0 ± 0.7 | 0.9 ± 10.9% |
| A. CING | 2.2 ± 0.6 | 2 ± 0.5 | −4.9 ± 15.7% | 2.3 ± 0.8 | 2.3 ± 0.7 | 3.6 ± 12.5% |
| OCC CTX | 1.8 ± 0.6 | 1.6 ± 0.5 | −6.5 ± 12.1% | 1.8 ± 0.7 | 1.8 ± 0.6 | 2.1 ± 10.0% |
| PAR CTX | 2.0 ± 0.6 | 1.8 ± 0.5 | −6.1 ± 9.8% | 2.0 ± 0.7 | 2.0 ± 0.6 | 1.0 ± 10.4% |
| TEMP CT | 3.4 ± 0.8 | 3.2 ± 0.8 | −5.3 ± 10.0% | 3.4 ± 1.0 | 3.4 ± 0.9 | 0.2 ± 8.6% |
| SUB GEN | 2.4 ± 0.7 | 2.3 ± 0.5 | −1.5 ± 18.1% | 2.6 ± 1.0 | 2.6 ± 0.8 | 5.4 ± 18.0% |
| INSULA | 3.4 ± 0.8 | 3.2 ± 0.7 | −4.1 ± 10.2% | 3.6 ± 1.1 | 3.7 ± 1.0 | 2.3 ± 9.8% |
| AMYGDALA | 5.6 ± 1.7 | 5.4 ± 1.5 | −1.9 ± 16.5% | 5.8 ± 2.4 | 5.9 ± 2.5 | 2.0 ± 11.0% |
| HIPPOCAMPUS | 2.5 ± 0.9 | 2.3 ± 0.7 | −5.1 ± 14.4% | 2.6 ± 1.5 | 2.6 ± 1.5 | 0.5 ± 11.9% |
| SN/VTA | 4.6 ± 1.3 | 4.4 ± 1.2 | −4.5 ± 12.7% | 5.0 ± 2.5 | 5.1 ± 2.5 | 2.7 ± 10.8% |
| THALAMUS | 6.2 ± 1.9 | 5.9 ± 1.6 | −3.0 ± 11.7% | 6.3 ± 2.5 | 6.5 ± 2.6 | 2.8 ± 10.1% |
| UNCUS | 3.8 ± 1.2 | 3.6 ± 1.2 | −5.9 ± 17.5% | 4.0 ± 1.8 | 4.0 ± 1.9 | −1.1 ± 11.6% |
See PET methods for abbreviations